Professor Andrew Chan

Andrew T. Chan, MD, MPH is a physician-scientist at Massachusetts General Hospital (MGH) known for his work in cancer prevention, with a focus on the role of pharmacologic preventives, diet, and the gut microbiome in cancer. As a practicing gastroenterologist and molecular epidemiologist, he has pioneered precision prevention approaches through translational research which spans population cohorts to clinical trials.  

Professor Chan is the Daniel K. Podolsky Professor of Medicine at Harvard Medical School and Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School of Public Health. He holds leadership roles at MGH, including Chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital and Director of Epidemiology at the MGH Cancer Center. He is co-leader of the Cancer Epidemiology Program of the Dana-Farber Harvard Cancer Center.  

Among his honors, Professor Chan is an American Cancer Society Research Professor, an Outstanding Investigator of the U.S. National Cancer Institute (NCI), and an elected member of the American Society for Clinical Investigation and the Association of American Physicians. He serves on the NCI Director’s Board of Scientific Advisors, the Governing Board of the American Gastroenterological Association, the Population Sciences Working Group of the American Association for Cancer Research as past chair, and the Health Equity Committee of Stand Up to Cancer.